Position
Executive Director
Company
Immunocine Cancer Center
HoustonBiotechnologyHealth CareMedicalTherapeuticsDescription
Immunocine Cancer Center has appointed Vita S. Salsman as Executive Director to enhance its operational strategy and clinical programs. Salsman, a veteran in cell therapy with over two decades of experience in cancer immunotherapy, will lead the organization’s ongoing advancements in personalized cancer care.
Quick answer
Immunocine Cancer Center Appoints Vita S. Salsman as Executive Director (July 7, 2026). Immunocine Cancer Center is based in Houston, Texas, United States.
- Who is the new Executive Director at Immunocine Cancer Center?
- Immunocine Cancer Center named Vita S. Salsman Executive Director, announced July 7, 2026.
- What did Immunocine Cancer Center announce on July 7, 2026?
- Immunocine Cancer Center has appointed Vita S. Salsman as Executive Director to enhance its operational strategy and clinical programs. Salsman, a veteran in cell therapy with over two decades of experience in cancer immunotherapy, will lead the organization’s ongoing advancements in personalized cancer care.
- What does Immunocine Cancer Center do?
- Immunocine Cancer Center is advancing a personalized approach to cancer treatment through its proprietary dendritic cell immunotherapy platform.
- Where is Immunocine Cancer Center based?
- Immunocine Cancer Center is based in Houston, Texas, United States.
- Which similar companies made leadership changes around the same time?
- Illuminare Biotechnologies (July 14, 2026), Ascidian Therapeutics (July 21, 2026), First Ascent Biomedical (June 22, 2026) and Harmony Biosciences (July 23, 2026) also announced leadership changes within 45 days of Immunocine Cancer Center.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Illuminare Biotechnologies Appoints Brian Longstreet as Chief Executive Officer (July 14, 2026)
- Ascidian Therapeutics Appoints Daniel Rosan as President (July 21, 2026)
- First Ascent Biomedical Appoints Raymond Rodriguez-Torres as President (June 22, 2026)
- Harmony Biosciences Appoints Stephen Mollichella as Interim CFO (July 23, 2026)
- Imugene Limited Announces Resignation of CEO Leslie Chong Effective Immediately (July 27, 2026)
- Bristol Myers Squibb Appoints Mayada Al-Ahmad as General Manager of Saudi Arabia and Gulf Countries (June 17, 2026)
Who to call at Immunocine Cancer Center, and when
A new leader at Immunocine Cancer Center brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Immunocine Cancer Center raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Immunocine Cancer Center, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Immunocine Cancer Center. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Immunocine Cancer Center changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Immunocine Cancer Center changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.